JPH11510373A5 - - Google Patents
Info
- Publication number
- JPH11510373A5 JPH11510373A5 JP1997504247A JP50424797A JPH11510373A5 JP H11510373 A5 JPH11510373 A5 JP H11510373A5 JP 1997504247 A JP1997504247 A JP 1997504247A JP 50424797 A JP50424797 A JP 50424797A JP H11510373 A5 JPH11510373 A5 JP H11510373A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9513074.6A GB9513074D0 (en) | 1995-06-27 | 1995-06-27 | Novel anigen |
| GB9513074.6 | 1995-06-27 | ||
| PCT/GB1996/001549 WO1997001638A1 (en) | 1995-06-27 | 1996-06-27 | Omp26 antigen from haemophilus influenzae |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008226372A Division JP2009034107A (ja) | 1995-06-27 | 2008-09-03 | インフルエンザ菌由来のｏｍｐ２６抗原 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH11510373A JPH11510373A (ja) | 1999-09-14 |
| JPH11510373A5 true JPH11510373A5 (enExample) | 2004-10-14 |
Family
ID=10776746
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9504247A Pending JPH11510373A (ja) | 1995-06-27 | 1996-06-27 | インフルエンザ菌由来のｏｍｐ２６抗原 |
| JP2008226372A Pending JP2009034107A (ja) | 1995-06-27 | 2008-09-03 | インフルエンザ菌由来のｏｍｐ２６抗原 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008226372A Pending JP2009034107A (ja) | 1995-06-27 | 2008-09-03 | インフルエンザ菌由来のｏｍｐ２６抗原 |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US6245338B1 (enExample) |
| EP (1) | EP0835313B1 (enExample) |
| JP (2) | JPH11510373A (enExample) |
| KR (1) | KR19990028423A (enExample) |
| CN (1) | CN1144875C (enExample) |
| AT (1) | ATE317013T1 (enExample) |
| AU (1) | AU708061B2 (enExample) |
| CA (1) | CA2225405A1 (enExample) |
| DE (1) | DE69635783T2 (enExample) |
| ES (1) | ES2259443T3 (enExample) |
| GB (1) | GB9513074D0 (enExample) |
| MX (1) | MX9710412A (enExample) |
| NO (1) | NO976119L (enExample) |
| NZ (1) | NZ311120A (enExample) |
| RU (1) | RU2221045C2 (enExample) |
| TW (1) | TW457247B (enExample) |
| WO (1) | WO1997001638A1 (enExample) |
| ZA (1) | ZA965482B (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355450B1 (en) | 1995-04-21 | 2002-03-12 | Human Genome Sciences, Inc. | Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof |
| US6468765B1 (en) | 1995-04-21 | 2002-10-22 | Human Genome Sciences, Inc. | Selected Haemophilus influenzae Rd polynucleotides and polypeptides |
| GB9904183D0 (en) * | 1999-02-24 | 1999-04-14 | Smithkline Beecham Biolog | Novel compounds |
| EP1162999B1 (en) | 1999-03-19 | 2006-11-29 | Glaxosmithkline Biologicals S.A. | Vaccine against Streptococcus pneumoniae |
| GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| AU2002211999A1 (en) * | 2000-10-02 | 2002-04-15 | Id Biomedical Corporation | Haemophilus influenzae antigens and corresponding DNA fragments |
| RU2185191C1 (ru) * | 2001-02-01 | 2002-07-20 | Ростовский научно-исследовательский институт микробиологии и паразитологии | Способ получения антигенного препарата haemophilus influenzae типа b (hib) |
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| DK2255826T3 (en) | 2002-08-02 | 2016-06-20 | Glaxosmithkline Biologicals Sa | Neisserial vaccine compositions comprising a combination of antigens. |
| BRPI0609460A2 (pt) * | 2005-03-30 | 2010-04-13 | Novartis Vaccines & Diagnostics Inc | haemophilus influenzae tipo b |
| CN100357318C (zh) * | 2005-10-11 | 2007-12-26 | 中山大学 | 美人鱼发光杆菌外膜蛋白w和编码序列及其制备方法和应用 |
| KR100743604B1 (ko) * | 2005-12-05 | 2007-07-27 | 볼보 컨스트럭션 이키프먼트 홀딩 스웨덴 에이비 | 차량용 머플러 구조 |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| PL3017827T3 (pl) | 2005-12-22 | 2019-04-30 | Glaxosmithkline Biologicals Sa | Szczepionka z koniugatem polisacharydu pneumokokowego |
| NO346497B1 (no) | 2006-01-17 | 2022-09-05 | Arne Forsgren | Overflateeksponert haemophilus influenzae protein (protein E, pE) |
| US9610339B2 (en) | 2007-06-26 | 2017-04-04 | Glaxosmithkline Biologicals, S.A. | Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates |
| GB201003922D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Conjugation process |
| GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| JP2013521326A (ja) | 2010-03-10 | 2013-06-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
| GB201103836D0 (en) | 2011-03-07 | 2011-04-20 | Glaxosmithkline Biolog Sa | Conjugation process |
| EP2717909B1 (en) | 2011-06-04 | 2017-12-06 | Rochester General Hospital Research Institute | Compositions and methods related to p6 of haemophilus influenzae |
| RU2727476C2 (ru) * | 2012-04-26 | 2020-07-21 | Новартис Аг | Антигены и антигенные композиции |
| CN104370997B (zh) * | 2014-09-24 | 2018-07-31 | 陈辉 | 去除生物制品中细菌内毒素的试剂盒、方法及其生物制品的制备方法 |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
| GB201621686D0 (en) | 2016-12-20 | 2017-02-01 | Glaxosmithkline Biologicals Sa | Novel methods for inducing an immune response |
| FR3066920A1 (fr) | 2017-05-30 | 2018-12-07 | Glaxosmithkline Biologicals S.A. | Nouveaux procedes de fabrication d'un adjuvant |
| WO2019106192A1 (en) | 2017-12-01 | 2019-06-06 | Glaxosmithkline Biologicals Sa | Saponin purification |
| US20210283238A1 (en) | 2018-08-07 | 2021-09-16 | Glaxosmithkline Biologicals Sa | Novel processes and vaccines |
| WO2020109365A1 (en) | 2018-11-29 | 2020-06-04 | Glaxosmithkline Biologicals Sa | Methods for manufacturing an adjuvant |
| CA3142300C (en) | 2019-06-05 | 2025-02-04 | Glaxosmithkline Biologicals Sa | SAPONIN PURIFICATION |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| GB202205833D0 (en) | 2022-04-21 | 2022-06-08 | Glaxosmithkline Biologicals Sa | Bacteriophage |
| WO2024017827A1 (en) | 2022-07-19 | 2024-01-25 | Glaxosmithkline Biologicals Sa | Continuous process for vaccine production |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0462210B1 (en) * | 1989-03-09 | 1994-09-07 | Praxis Biologics, Inc. | Vaccines for nontypable haemophilus influenzae |
| GB8924473D0 (en) * | 1989-10-31 | 1989-12-20 | Connaught Lab | Outer membrane protein p1 and peptides of haemophilus influenzae b |
| GB9224584D0 (en) * | 1992-11-23 | 1993-01-13 | Connaught Lab | Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases |
-
1995
- 1995-06-27 GB GBGB9513074.6A patent/GB9513074D0/en active Pending
-
1996
- 1996-06-27 ZA ZA9605482A patent/ZA965482B/xx unknown
- 1996-06-27 AU AU62363/96A patent/AU708061B2/en not_active Ceased
- 1996-06-27 ES ES96920996T patent/ES2259443T3/es not_active Expired - Lifetime
- 1996-06-27 AT AT96920996T patent/ATE317013T1/de not_active IP Right Cessation
- 1996-06-27 RU RU98101249/13A patent/RU2221045C2/ru not_active IP Right Cessation
- 1996-06-27 DE DE69635783T patent/DE69635783T2/de not_active Expired - Lifetime
- 1996-06-27 JP JP9504247A patent/JPH11510373A/ja active Pending
- 1996-06-27 NZ NZ311120A patent/NZ311120A/en not_active IP Right Cessation
- 1996-06-27 CN CNB961951389A patent/CN1144875C/zh not_active Expired - Fee Related
- 1996-06-27 CA CA002225405A patent/CA2225405A1/en not_active Abandoned
- 1996-06-27 WO PCT/GB1996/001549 patent/WO1997001638A1/en not_active Ceased
- 1996-06-27 KR KR1019970709739A patent/KR19990028423A/ko not_active Ceased
- 1996-06-27 EP EP96920996A patent/EP0835313B1/en not_active Expired - Lifetime
- 1996-09-12 TW TW085111139A patent/TW457247B/zh not_active IP Right Cessation
-
1997
- 1997-12-18 MX MX9710412A patent/MX9710412A/es not_active IP Right Cessation
- 1997-12-22 US US08/996,408 patent/US6245338B1/en not_active Expired - Fee Related
- 1997-12-29 NO NO976119A patent/NO976119L/no not_active Application Discontinuation
-
1999
- 1999-05-13 US US09/310,847 patent/US6254875B1/en not_active Expired - Fee Related
- 1999-05-13 US US09/310,845 patent/US6284477B1/en not_active Expired - Fee Related
-
2000
- 2000-04-12 US US09/548,023 patent/US6313281B1/en not_active Expired - Fee Related
-
2008
- 2008-09-03 JP JP2008226372A patent/JP2009034107A/ja active Pending